research

Resources for Professionals

Micronutrient status in children and adolescents with Down syndrome: systematic review and meta-analysis

Down syndrome (DS) is the most common genetic disorder. To date, the scientific literature regarding…

Kim WarrenMarch 28, 2024

Resources for Professionals

Improving B-ALL Outcomes in Children With Down Syndrome

LEUKEMIA Improving B-ALL Outcomes in Children With Down Syndrome Tori Rodriguez, MA, LPC, AHC|January 5,…

Kim WarrenMarch 28, 2024

Health and Research – Other

Developing A Down Syndrome Health Instrument w/Dr. Stephanie Santoro

Dr. Stephanie Santoro from Massachusetts General Hospital's Down Syndrome Clinic discusses her research in developing…

Kim WarrenMarch 12, 2024

Resources for Professionals

National Advisory Council on Minority Health and Health Disparities (NACMHD) Working Group on Persons Living with Disabilities

Health disparities are well documented in the United States and are shaped by the unequal…

Kim WarrenMarch 6, 2024

Resources for Professionals

Modeling the Impact of Research Investment on Down Syndrome–Associated Alzheimer’s Disease

Individuals with Down syndrome (DS) are living longer than they used to. This trend has…

Kim WarrenJanuary 19, 2024

Health and Research – Other Resources for Professionals

New Therapies from Proven Ideas, MDSC 2023

This video discusses the repurposing existing drugs and therapies for new uses. Source: Massachusetts Down…

Kim WarrenDecember 15, 2023

Health and Research – Other

Understanding Research Participation, MDSC 2023

This video discusses why, how, and when families should consider participating in Down syndrome research.…

Kim WarrenDecember 15, 2023

Resources for Professionals

Adapting Eligibility Criteria for Prescribing FDA Approved Anti-amyloid Immunotherapeutics for Adults with Down Syndrome with Early-Stage Alzheimer’s Dementia

An international group of experts convened to determine prescribing criteria equivalences that would be inclusionary…

Kim WarrenJune 2, 2023

Resources for Professionals

Medical Vulnerability of Individuals with Down Syndrome to Severe COVID-19

Health conditions, immune dysfunction, and premature aging associated with trisomy 21 (Down syndrome, DS) may…

Rigsby RigsbyMay 3, 2022

Resources for Professionals

Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome

Studies suggest human trisomy 21 impacts several diseases in an age-dependent manner. Thus, understanding the…

Rigsby RigsbyApril 29, 2022

Micronutrient status in children and adolescents with Down syndrome: systematic review and meta-analysis

Improving B-ALL Outcomes in Children With Down Syndrome

Developing A Down Syndrome Health Instrument w/Dr. Stephanie Santoro

National Advisory Council on Minority Health and Health Disparities (NACMHD) Working Group on Persons Living with Disabilities

Modeling the Impact of Research Investment on Down Syndrome–Associated Alzheimer’s Disease

New Therapies from Proven Ideas, MDSC 2023

Understanding Research Participation, MDSC 2023

Adapting Eligibility Criteria for Prescribing FDA Approved Anti-amyloid Immunotherapeutics for Adults with Down Syndrome with Early-Stage Alzheimer’s Dementia

Medical Vulnerability of Individuals with Down Syndrome to Severe COVID-19

Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome

CONTACT LUMIND IDSC

QUICK LINKS

JOIN US